Related Experiment Video
Updated: Jul 21, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
When to suspect hypercoagulability and how to investigate it
1Department of Pathology, University of Alabama at Birmingham, AL 35233-7331, USA.
Abstract:
The authors summarize the current knowledge in the area of novel risk factors for venous thrombosis, both genetic and acquired causes of hypercoagulability. Because the list of genetic defects that predispose carriers to develop thrombosis has increased significantly in recent years, along with the available assays to test for them, hypercoagulability has been a subject of much discussion. This review highlights the issues on hypercoagulability that pathologists who are not specialists in coagulation should be familiar with, in order to provide consultation to other physicians. An educated approach to the diagnosis of this newly described group of disorders will ensure more cost-effective and efficient care to patients at risk.
More Related Videos
04:56Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management